Citation Impact
Citing Papers
A Gene Network Regulating Lysosomal Biogenesis and Function
2009 StandoutScience
The clinical symptoms of Parkinson's disease
2016 Standout
The European Physiotherapy Guideline for Parkinson’s Disease: Implications for Neurologists
2018
Prospective assessment of falls in Parkinson's disease
2001
Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trial
2018
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease
2002
Parkinson disease
2017 Standout
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
2007
Parkinson's disease
2021 Standout
Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure
2010
Syndemics and the biosocial conception of health
2017 Standout
Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study
2006
Hypothalamic regulation of sleep and circadian rhythms
2005 StandoutNature
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology
2014
Electromyographic Biofeedback in the Treatment of the Hemiplegic Hand
2003
Effects of stress on decisions under uncertainty: A meta-analysis.
2016
Parkinson's disease: The quintessential neuropsychiatric disorder
2011
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
2011 Standout
Cigarette smoking and the incidence of Parkinson's disease in two prospective studies
2001
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Smoking, nicotine and Parkinson's disease
2004
Exercise-induced neuroplasticity in human Parkinson's disease: What is the evidence telling us?
2015
Dopaminergic modulation of motor network dynamics in Parkinson's disease
2015
Parkinson's disease: clinical features and diagnosis
2008 Standout
Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA)
2004
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Stages in the development of Parkinson’s disease-related pathology
2004 Standout
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
2018
Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study
2012
Epidemiology of Parkinson's disease
2006 Standout
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
Polymorphisms in dopamine receptors: what do they tell us?
2000
Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data
2017
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
2014
The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?
2018
Pains in Parkinson disease—many syndromes under one umbrella
2012
Parkinson's disease
2009 Standout
The role of executive function and attention in gait
2007 Standout
Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson’s disease
2007
Sleepiness in Parkinson's disease: A controlled study
2003
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
2011
Parkinson's disease symptoms: The patient's perspective
2010
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
2004 Standout
Sensory aspects of movement disorders
2013
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
Parkinson's disease
2015 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Phospholipase C β4 in the Medial Septum Controls Cholinergic Theta Oscillations and Anxiety Behaviors
2009
Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
2015
Depression and Quality of Life in Older Persons: A Review
2015 Standout
Accuracy of clinical diagnosis of progressive supranuclear palsy
2003
Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy
2007
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
2013
Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model
2016 Standout
The ReSPonD trial - rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen
2013
Cognitive impairment in 873 patients with idiopathic Parkinson's disease
2008
Treatment interventions for Parkinson's disease: an evidence based assessment
2002
Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson's disease
2001
The neural basis of human error processing: Reinforcement learning, dopamine, and the error-related negativity.
2002 Standout
Sensory and cognitive functions of the basal ganglia
1997
Sarcopenia
2019 Standout
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
2012 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Gender and non motor fluctuations in Parkinson's disease: A prospective study
2016
Synthesis of Selective Agonists for the α7 Nicotinic Acetylcholine Receptor with In Situ Click-Chemistry on Acetylcholine-Binding Protein Templates
2012 StandoutNobel
Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists
2003
Effects of rhythmic sensory stimulation (auditory, visual) on gait in Parkinson’s disease patients
2008
Effect of cognitive and motor tasks on postural stability in Parkinson's disease: A posturographic study
2003
Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
2016
Attention and the control of posture and gait: a review of an emerging area of research
2002 Standout
Chronic Oral Nicotine Normalizes Dopaminergic Function and Synaptic Plasticity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Primates
2006
Decision Making Under Objective Risk Conditions–a Review of Cognitive and Emotional Correlates, Strategies, Feedback Processing, and External Influences
2015
Non-motor features of Parkinson disease
2017 Standout
Post-Traumatic Growth After a Myocardial Infarction: A Matter of Personality, Psychological Health, or Cognitive Coping?
2008 Standout
Arbitrary visuomotor mapping during object manipulation in Parkinson's disease
2009
Excessive Daytime Sleepiness in Patients with Parkinsonʼs Disease
2011
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
New approaches to understanding hallucinations in Parkinson’s disease: phenomenology and possible origins
2007
Postural deformities in Parkinson's disease
2011
Physical activity and exercise attenuate neuroinflammation in neurological diseases
2016
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
2011
Motor recovery after stroke: a systematic review
2009 Standout
Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease
2010
Sleepiness and unintended sleep in Parkinson’s disease
2003
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
The WHO-5 Well-Being Index: A Systematic Review of the Literature
2015 Standout
Dopamine, learning and motivation
2004 Standout
Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment
2009
Balance
2013
Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
2012
Criteria for the diagnosis of corticobasal degeneration
2013 Standout
Reliability and validity of the S panish version of the W orld H ealth O rganization‐F ive W ell‐B eing I ndex in elderly
2012
The Validity of the WHO-5 as an Early Screening for Apathy in an Elderly Population
2012
Ottawa Panel Evidence-Based Clinical Practice Guidelines for Post-Stroke Rehabilitation
2006
Diagnosis and Treatment of Parkinson Disease
2020 Standout
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
2000 Standout
Verbal Fluency Task Affects Gait in Parkinson's Disease with Motor Freezing
1998
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
2009 Standout
Preclinical (premotor) Parkinson’s disease
2000
Excessive daytime sleepiness in Parkinson’s disease
2004
Rehabilitation of walking with electromyographic biofeedback in foot-drop after stroke.
1994
Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease
2018
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease
2010
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
2013
Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease
2007
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
The Interaction of Person-Affect-Cognition-Execution (I-PACE) model for addictive behaviors: Update, generalization to addictive behaviors beyond internet-use disorders, and specification of the process character of addictive behaviors
2019 Standout
Beside the Geriatric Depression Scale: the WHO‐Five Well‐being Index as a valid screening tool for depression in nursing homes
2013
The MoCA
2010 Standout
Neurovascular Coupling in Parkinson's Disease Patients: Effects of Dementia and Acetylcholinesterase Inhibitor Treatment
2010
An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines
2002
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD
2002
How pain arises in P arkinson's disease?
2013
Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson’s disease: a systematic review and meta-analysis
2017
Utilization of rehabilitation therapy services in Parkinson disease in the United States
2017
Diffusion tensor imaging in parkinsonian syndromes
2013
Works of Georg Ebersbach being referenced
Nonpharmacological treatments for patients with Parkinson's disease
2015
Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom
2010
Myopathy causing camptocormia in idiopathic Parkinson's disease: A multidisciplinary approach
2009
Sociocultural differences in gait
2000
Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration
1999
Diffusion tensor imaging of the corpus callosum differentiates corticobasal syndrome from Parkinson’s disease
2010
Directional bias of initial visual exploration A symptom of neglect in Parkinson's disease
1996
Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease
2010
Impact of Physical Exercise on Reaction Time in Patients With Parkinson's Disease—Data From the Berlin BIG Study
2013
Selective diplopia in Parkinson's disease: A special subtype of visual hallucination?
2007
Trick maneuvers in cervical dystonia: Investigation of movement- and touch-related changes in polymyographic activity
1999
Progression of falls in postmortem-confirmed Parkinsonian disorders
1999
Amplitude-oriented exercise in Parkinson’s disease: a randomized study comparing LSVT-BIG and a short training protocol
2014
Comparing exercise in Parkinson's disease—the Berlin BIG Study
2010
Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery
2013
Clinical characteristics of the geste antagoniste in cervical dystonia
2001
Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: A neuropsychological and psychophysiological study
2009
Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy
1999
Perseverative motor behaviour in Parkinson's disease
1994
Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel
2011
Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor
1997
Gleichgewichtsstörungen bei idiopathischer Parkinson-Erkrankung
2002
Lewy body dementia and Parkinson’s disease with dementia
2008
Pain intensity on and off levodopa in patients with Parkinson's disease
2009
Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument
2007
Interference of rhythmic constraint on gait in healthy subjects and patients with early parkinson's disease: Evidence for impaired locomotor pattern generation in early Parkinson's disease
1999
Whole Body Vibration Versus Conventional Physiotherapy to Improve Balance and Gait in Parkinson’s Disease
2008
Involvement of motor pathways in corticobasal syndrome detected by diffusion tensor tractography
2008
Moral decision-making and theory of mind in patients with idiopathic Parkinson’s disease.
2013
Screening for cognitive impairment in Parkinson’s disease – which marker relates to disease severity?
2006
Scales in Parkinson’s disease
2006
Dopamine D4 receptor polymorphism and idiopathic Parkinson's disease
1999
Sudden daytime sleep onset in Parkinson's disease: Polysomnographic recordings
2001
Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)
2015
LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease
2012
Treating chronic hemiparesis with modified biofeedback.
1989
Influence of Concurrent Tasks on Gait: A Dual-Task Approach
1995
Assessment of Nonmotor Fluctuations Using a Diary in Advanced Parkinson’s disease
2016
The DONPAD-study — Treatment of dementia in patients with Parkinson’s disease with donepezil
2006
Nonmotor fluctuations in Parkinson disease
2013